Title
Category
Credits
Event date
Cost
  • CME Activities
  • Critical Care
  • Emergency
  • Imaging
  • Neurointervention
  • Neurology
  • Stroke
  • Telemedicine
  • Thrombolysis
  • Thrombolytics
  • Participation
$0.00
Join TeleSpecialists TeleNeurologist Sam Saha, MD as he shares details about the latest clinical trials supporting imaging-guided thrombolysis and thrombectomy decision-making that have demonstrated net benefit in subsets of patients with unknown onset of symptoms, most commonly after waking up. With wider implementation of advanced imaging augmented by artificial intelligence software, there is an argument for pushing stroke treatment boundaries long established by clinical decision-making alone.
  • Anatomy
  • CME Activities
  • Critical Care
  • Dizziness
  • Emergency
  • Neurology
  • Stroke
  • Participation
$0.00
Join TeleSpecialists' physician Dr. Theresa Sevilis, a board-certified neurologist, as she reviews the anatomy and clinical syndromes associated with posterior circulation strokes. She will discuss the use of screening tools and examination techniques to improve the identification of posterior circulation strokes. She will also review the evidence and treatment options of posterior circulation strokes.
  • Alteplase
  • Best Practices
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Telemedicine
  • Participation
$0.00
Join us in celebrating National Stroke Awareness Month and National Neuroscience Nurses Week as our panel reviews several TeleSpecialists’ best practice recommendations and discusses new focus areas for the improvement of stroke care.
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Nursing Continuing Education
  • Stroke
  • Tenecteplase
  • Thrombolytics
  • Nursing Education Hours
  • Participation
$0.00
Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence and practical considerations for use of Tenecteplase in stroke therapy.  
  • CME Activities
  • Critical Care
  • Disorders
  • Emergency
  • Epilepsy
  • Neurology
  • Seizure
$0.00
Seizure medications have greatly increased in number over the past decade.  This lecture will go over the new categories of medications, the best application of each one, and limitations of use including monitoring parameters.  Both emergent, inpatient, and outpatient topics will be covered to allow for better prescribing practices as most medications started in one setting tend to affect the other two settings.  
  • Alteplase
  • Best Practices
  • CME Activities
  • Critical Care
  • Emergency
  • Nursing Continuing Education
  • Stroke
  • Nursing Education Hours
  • Participation
$0.00
Evidence has shown that the benefits of IV tPA and thrombectomy in acute ischemic stroke are time-dependent.  Therefore, AHA guidelines have made certain recommendations regarding door-to-needle and door-to-groin puncture time.  Despite this, the majority of acute ischemic patients who receive tPA and thrombectomy are not treated within this time.  Stroke quality programs have been shown to improve doo-to-needle and door-to-groin puncture time, thus improving outcomes in the care of acute ischemic stroke.  This program will discuss best practices in acute stroke care to assist healthcare pr
  • Alteplase
  • Best Practices
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Nursing Continuing Education
  • Stroke
  • Tenecteplase
  • Thrombolytics
  • Nursing Contact Hours
04/28/2022
$0.00
Join TeleSpecialists Dr. Theresa Sevilis, board-certified vascular neurologist to review the American Heart Association Guidelines for the Early Management of Patients with Acute Ischemic Stroke.  Dr. Sevilis will discuss the indications, relative contraindications, and absolute contraindications for thrombolytics, provide cases for review, and discuss how to use the Guidelines in the decision making process.  She will highlight the most commonly asked questions surrounding thrombolytic administration and discuss the new utilization of tenecteplase in place of alteplase.